'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option
- PMID: 24830805
- DOI: 10.1002/pon.3576
'What is this active surveillance thing?' Men's and partners' reactions to treatment decision making for prostate cancer when active surveillance is the recommended treatment option
Abstract
Objective: In the past decade, localised prostate cancer (LPC) management has been shifting from three radical treatment options (radical prostatectomy, external beam radiotherapy, or brachytherapy) to also include active surveillance (AS). This study examines men with LPC and partners' experiences of choosing between AS and radical treatments, and their experiences of AS when selected.
Methods: A qualitative descriptive research design was used. Interviewed participants were men, and partners of men, who either had chosen radical treatment immediately following diagnosis or had been on AS for at least 3 months. AS was the recommended treatment. Transcribed interviews were thematically analysed and inter-rater reliability integrated.
Results: Twenty-one men and 14 partners participated. Treatment decisions reflected varied reactions to prostate cancer information, regularly described as contradictory, confusing, and stressful. Men and partners commonly misunderstood AS but could describe monitoring procedures. Partners often held the perception that they were also on AS. Men and partners usually coped with AS but were sometimes encumbered by treatment decision-making memories, painful biopsies, ongoing conflicting information, and unanswered medical questions. Radical treatment was selected when cancer progression was feared or medically indicated. Some preferred doctors to select treatments.
Conclusions: To reduce distress frequently experienced by men diagnosed with LPC and their partners during treatment decision making and ongoing AS monitoring, the following are needed: improved community and medical awareness of AS; consistent information about when radical treatment is required; and consistent, unbiased information on treatment options, prognostic indicators, and side effects. Regularly updated decisional support information/aids incorporating men's values are imperative.
Keywords: active surveillance; cancer; oncology; prostate cancer; qualitative research.
Copyright © 2014 John Wiley & Sons, Ltd.
Similar articles
-
Active surveillance for low-risk localized prostate cancer: what do men and their partners think?Fam Pract. 2017 Feb;34(1):90-97. doi: 10.1093/fampra/cmw123. Epub 2016 Dec 29. Fam Pract. 2017. PMID: 28034917 Free PMC article.
-
Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer.Oncol Nurs Forum. 2009 Jan;36(1):89-96. doi: 10.1188/09.ONF.89-96. Oncol Nurs Forum. 2009. PMID: 19136342
-
Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.Urology. 2004 Apr;63(4):751-6. doi: 10.1016/j.urology.2003.11.017. Urology. 2004. PMID: 15072894
-
Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.Prescrire Int. 2012 Oct;21(131):242-8. Prescrire Int. 2012. PMID: 23185849 Review.
-
Decision-Making in Prostate Cancer – Choosing Active Surveillance Over Other Treatment Options: A Literature Review.Urol Nurs. 2017 Jan-Feb;37(1):15-22. Urol Nurs. 2017. PMID: 29240360 Review.
Cited by
-
Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study.BMJ. 2020 Oct 7;371:m3503. doi: 10.1136/bmj.m3503. BMJ. 2020. PMID: 33028540 Free PMC article.
-
Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: the ProtecT three-arm RCT.Health Technol Assess. 2020 Aug;24(37):1-176. doi: 10.3310/hta24370. Health Technol Assess. 2020. PMID: 32773013 Free PMC article. Clinical Trial.
-
Qualitative study on decision-making by prostate cancer physicians during active surveillance.BJU Int. 2017 Jul;120(1):32-39. doi: 10.1111/bju.13651. Epub 2016 Oct 2. BJU Int. 2017. PMID: 27611479 Free PMC article.
-
Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.Am J Prev Med. 2015 Dec;49(6 Suppl 5):S483-8. doi: 10.1016/j.amepre.2015.08.016. Am J Prev Med. 2015. PMID: 26590643 Free PMC article.
-
A Qualitative Study of Men's Experiences Using Navigate: A Localized Prostate Cancer Treatment Decision Aid.MDM Policy Pract. 2023 Sep 13;8(2):23814683231198003. doi: 10.1177/23814683231198003. eCollection 2023 Jul-Dec. MDM Policy Pract. 2023. PMID: 37719768 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous